Clinical trials of combined vaccine against flu, COVID-19 may begin in 2022
14 Jan in 22:00 The Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry plans to begin clinical trials of a combined vaccine against the coronavirus and flu in the middle of 2022, Center’s Director Alexander Gintsburg said, TASS reports. "[Clinical trials] are in the work schedule. We are doing this, we created a technology which allows to hope that it will be possible to create such a vaccine. ... We are planning to begin clinical trials by the middle, the second half of next year. If before this we conduct everything on animals and wi...
Source: vestnikkavkaza.net